EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 17th, 2025 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJanuary 17th, 2025 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is made by and between Odyssey Therapeutics, Inc., a Delaware corporation (the “Company”, and together with any parent company, any and all direct or indirect subsidiaries of the Company, and their affiliates, in each case, existing now or in the future, “Odyssey”), and Gary Glick (the “Executive”), effective as of January 1, 2025 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 17th, 2025 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJanuary 17th, 2025 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is made by and between Odyssey Therapeutics, Inc., a Delaware corporation (the “Company”, and together with any parent company, any and all direct or indirect subsidiaries of the Company, and their affiliates, in each case, existing now or in the future, “Odyssey”), and Julie Clauss (the “Executive”) on the date listed on the signature page hereto, and shall become effective as of, and conditional upon, the day prior to the Public Trading Date (as defined below) (such date, the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 17th, 2025 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJanuary 17th, 2025 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is made by and between Odyssey Therapeutics, Inc., a Delaware corporation (the “Company”, and together with any parent company, any and all direct or indirect subsidiaries of the Company, and their affiliates, in each case, existing now or in the future, “Odyssey”), and Jason Haas (the “Executive”) on the date listed on the signature page hereto, and shall become effective as of, and conditional upon, the day prior to the Public Trading Date (as defined below) (such date, the “Effective Date”).